Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2006-11-23

Clinical Trial Update: Intravitreal Bevacizumab for Retinal Disorders [NA]

View source ↗

Summary

An update on a clinical trial evaluating intravitreal bevacizumab for retinal disorders including wet age-related macular degeneration, macular edema, and proli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Avastin (bevacizumab)

Snippet

Sponsor: Narayana Nethralaya | Conditions: Wet AMD, Macular Oedema | NA | Status: UNKNOWN